Gilenya withdrawal may trigger the return of disease act.

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Gilenya withdrawal may trigger the return of disease act.

Postby MSUK » Thu Jan 25, 2018 6:54 am

Gilenya withdrawal may trigger the return of pre-treatment disease activity

It is difficult to identify patients at risk of disease reactivation. So in a recent study scientists at Cerrahpasa School of Medicine, Istanbul University in Turkey compared the demographic and clinical features of patients experiencing severe disease reactivation (SDR) after Gilenya was stopped, with those of patients who did not...Read more - http://www.ms-uk.org/gilenya-withdrawal-may-trigger-return-pre-treatment-disease-activity

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service


cron